State-of-the-Art-Clinical Symposium

State-of-the-Art Clinical Symposium

In Person

Logo

About the Event

Date:April 12–14, 2024

Location:Chicago, IL

Credit:CME: 9.50, ABIM MOC: 9.50

On Demand:Not Available

Registerexternal link opens in a new tab.

FIT@SOTA

The Fellows in Training (FIT) at SOTA program takes place on April 12. There is no other SOTA programming on that date. FITs interested in attending FIT@SOTA on April 12 and SOTA April 13-14, should select the FIT@SOTA pass when registering. See FIT@SOTA information.

 

Note: This activity is not CME or MOC-accredited.

During the State-of-the-Art Clinical Symposium (SOTA), key opinion leaders will deliver a range of content in areas such as therapeutic developments, recent research findings, and scientific advances, in an environment conducive to dialogue and networking.

Target Audience
Rheumatologists (physicians) in clinical care and/or research, fellows in training, division directors, program directors, assistant program directors, physician assistants, nurse practitioners, pharmacists, nurses, and epidemiologists.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss the most up-to-date evidence-based treatment approaches in the management of rheumatic diseases
  • Identify and describe recent scientific and clinical advances regarding the pathogenesis of rheumatology

See meeting and on-demand access information from the 2023 meeting in the State-of-the-Art Clinical Symposium 2023 section below.


Program Schedule & Syllabi

State-of-the-Art Clinical Symposium 2024 Full Schedule

Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.


Registration Fees

Early Rate (through December 31, 2023)
ACR/Fellow of the ACR – $440
ACR Student – $0
ACR Transitional –$195
ARP Student – $0
ARP Member – $340
ARP Transitional – $195

General Rate (through February 29, 2024)
ACR/Fellow of the ACR – $550
ACR Student – $0
ACR Transitional – $295
ARP Student – $0
ARP Member – $450
ARP Transitional – $295

Late Rate (begins March 1, 2024)
ACR/Fellow of the ACR – $630
ACR Student – $0
ACR Transitional – $395
ARP Student – $0
ARP Member – $530
ARP Transitional – $395

Small Team Members: All Small Team members will automatically receive a member discount on ACR SOTA registration. The Small Team physician member will receive the ACR member discount and all other team members will receive the ARP member discount.

Early Rate (through December 31, 2023)
Physician – $650
Interprofessional Team Member – $500*
Developing Country – $0**

General Rate (through February 29, 2024)
Physician – $820
Interprofessional Team Member – $670*
Developing Country – $0**

Late Rate (begins March 1, 2024)
Physician – $950
Interprofessional Team Member – $800*
Developing Country – $0**

*Interprofessional Professional Team Members: Includes nurses, physician assistants, pharmacists, occupational therapists, physical therapists, health educators, social workers, psychologists, dietitians, nonphysician practice managers, and office administrators. To be eligible for the reduced fee, interprofessional potential members must provide evidence of work to education@rheumatology.org.

**Developing Country Potential Members: To be eligible for the reduced fee, potential members from countries with low-income and lower-middle-income economies, as determined by the World Bank, must provide evidence of work and residence address.

Cancellation & Refund Policy

  • Cancellations and refund requests must be received in writing by January 31, 2024, to education@rheumatology.org.
  • Refunds will not be provided for cancellations received after the cancellation deadline.
  • An administration fee will be deducted: $50 for members; $100 for nonmembers.
  • No-shows will not receive a refund.
  • ACR is not responsible for airfare, hotel, or other costs incurred by participants in the event of a program or registration cancellation, or delays or cancellations due to inclement weather.
  • All refund requests will be processed after the meeting. No refunds will be issued on-site.
  • Cancelled registrations are nontransferable.

Hotel

Fairmont Chicago, Millennium Park
200 N Columbus Dr.
Chicago, IL 60601
312-565-8000

Reservations after March 20 will be handled on a case-by-case basis and the ACR cannot guarantee availability. Please contact events@rheumatology.org for assistance.

Travel

Airports
Chicago Midway Airport (MDW) – 12.5 miles from Fairmont Chicago Millennium Park
Chicago O’Hare Airport (ORD) – 24 miles from the Fairmont Chicago Millennium Park

Ground Transportation
MDW Ground Transportation Details

MDW airport taxis - taxis can be found at the lower-level inner lane in the section specified for taxis. Taxi rides are approximately 15 minutes to the Fairmont Chicago Millennium Park and cost approximately $35–$45.

ORD Ground transportation Details

Rental Cars
Rental cars can be acquired at designated areas in each airport.


Press Registration

The American College of Rheumatology welcomes members of the press to write about research presented at our meetings. Complimentary registration is provided to approved members of the press to allow them to attend sessions on site.
See press registration details


Corporate Support

The American College of Rheumatology thanks our corporate supporters and partners for their commitment to advancing rheumatology by supporting ACR and ARP programs and initiatives.

See current supporters, guidelines, and benefits of supporting the ACR.

Interested in exhibiting at SOTA?
Review the Exhibitor and Sponsorship Prospectus.

Exhibits and Sponsorship Questions?
Contact Kat Dennis (kdennis@rheumatology.org).

CME

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.

Designation Statement
The ACR designates this blended learning activity encompassing live and on demand activity for a maximum of 9.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME credit must be claimed by April 11, 2025.

MOC

MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

MOC points must be claimed by April 11, 2025.

ABIM CME/ MOC accredited

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Nature of Financial Relationships
Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
  7. Independent contractor
  8. Ownership interest
  9. Royalties
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

SOTA 2024 Financial Relationships Disclosures

SOTA 2024 Mitigation Spreadsheet

View ACR's ACCME disclosure practices

See 2023 disclosures in the 2023 meeting section below.

SOTA 2023 was one of the meetings held during the ACR Education Exchange. See key takeaways from your colleagues that attended SOTA 2023.

CME & MOC Information

CME: 12.00
ABIM MOC: 12.00

CME credit must be claimed by March 26, 2024 at 11:59 PM ET.

MOC points must be claimed by December 31, 2023 at 11:59 PM ET.

See information about CME and MOC for all ACR Education Exchange meetings on the ACR Education Exchange page.

Target Audience
Rheumatologists, physicians, and health care providers who care for patients with rheumatic diseases, and those interested or engaged in rheumatology research.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss the most up-to-date evidence-based treatment approaches in the management of rheumatic diseases
  • Identify and describe recent scientific and clinical advances regarding the pathogenesis of rheumatic diseases

Program Schedule & Syllabi

View State-of-the-Art Clinical Symposium Schedule

ACR Education Exchange Program Schedule at a Glance

Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.


On-Demand Access

On-demand access includes recordings of each lecture and the 10-minute Q&A which followed most lectures.

On-demand access is available May 10, 2023–April 29, 2024.

Registration Fees

ACR/ARP Members: $350
Potential Members: $500

Register for On-Demand Access


Financial Relationships Disclosures

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Nature of Financial Relationships
Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
  7. Independent contractor
  8. Ownership interest
  9. Royalties
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

 

The planning committee and faculty reported the following disclosures.

The following planning committee members have no relevant financial relationship(s) with ineligible companies to disclose.

  • Charles Haberkern, MBA
  • Rebecca Shepherd, MD, MBA
  • Marcus Snow, MD
  • Sarah Bayefsky, MD
  • Adam Kilian, MD
  • Bethany Marston, MD
  • Benjamin Smith, PA-C
  • Irene Tan, MD
  • Melesia Tillman
  • Saud Abaalkhail, MD
  • Seth Berney, MD
  • Anna Broder, MD, MSc
  • Jim Oates, MD
  • Debendra Pattanaik, MD
  • Natasha Ruth, MD
  • Sarah Baxter, MD, PhD
  • Margaret Chang, MD, PhD
  • Patrick Corrigan, DPT, PhD
  • Ali Duarte, MD
  • Ruth Fernandez Ruiz, MD, MSc
  • Tate Johnson, MD
  • Emily Smitherman, MD
  • Louise Thoma, PhD, DPT
  • Yu (Ray) Zuo, MD, MS
  • Sean Fahey, MD
  • Rebecca Manno, MD, MHS
  • Ann Cameron Barr, MD
  • Rashmi Dhital, MD
  • Mohanad Elfishawi, MBBCh, MS
  • Mario David Felix, MD
  • Ibtissam Gad, MD
  • Guy Katz, MD
  • Karen Kruzer, MD
  • Sara T. Patrizi, DO
  • Jessica Perfetto, MD
  • Didem Saygin, MD
  • Austin Wheeler, MD
  • Matthew Bunyard, MD
  • Kevin Byrum, MD
  • Sobia Hassan, RhMSUS, MRCP, MBBS
  • Lisa Korn, PhD
  • Aman Kugasia, MD
  • Liana Fraenkel, MD, MPH

The following planning committee members have relevant financial relationship(s) with ineligible companies to disclose.

  • Fotios Koumpouras, MD – AstraZeneca (Consultant/Speaker), GSK (Consultant/Speaker), Aurinia (Consultant), BMS (Consultant), Novartis (Consultant)
  • Laura Sampson, PA-C – Novartis (Advisor Board), Eli Lilly (Advisory Board)
  • Vaneet Sandhu, MD – GSK (Speaker), Aurinia (Speaker)
  • Stacey Tarvin, MD – Pfizer (PI), UCB (PI), Roche (PI)
  • Randy Cron, MD, PhD – Sobi (Consultant, CT Support), Pfizer (CT Adjudication Committee), Apollo Therapeutics (Consultant), AbbVie (CT Adjudication Committee), MedStudy (Board Review Lecturer), Lilly & Vindico Medical Education (Curbside Consultant/Speaker)
  • Eyal Muscal, MD, MSc – Sobi (Consultant, Advisory Board)
  • Shanthini Kasturi, MD, MS – GSK (Advisor)
  • Hanna Kim, MD – Eli Lilly (Research Support)
  • Maximilian Konig, MD – Argenx (Consultant), Revel (Consultant)
  • Bella Mehta, MBBS, MS – Novartis (Educational Content Development)
  • Naomi Patel, MD – FVC Health (Consultant), Alosa Health (Consultant)
  • Kam Nola, MS, PharmD – Eli Lilly (Stock)

View ACR's ACCME disclosure practices

View ACR Education Exchange 2023 Disclosures


Corporate Support

The American College of Rheumatology thanks our corporate supporters and partners for their commitment to advancing rheumatology by supporting ACR and ARP programs and initiatives.

See current supporters, guidelines, and benefits of supporting the ACR.

We use cookies on our website to improve our service to you and for security purposes. By continuing to use our site without changing your browser cookie settings, you agree to our cookie policy and the use of cookies. See ACR Policies